In silico and in vitro evaluation of kaempferol as a potential inhibitor of the SARS‐CoV‐2 main protease (3CLpro)

Eitemau Tebyg

• Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro)
  gan: Khan, Abbas, et al.
  Cyhoeddwyd: (2020)
• Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease
  gan: Yi Kuang, et al.
  Cyhoeddwyd: (2023-04-01)
• Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein
  gan: Khan, Abbas, et al.
  Cyhoeddwyd: (2020)
• Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation
  gan: Khan, Abbas, et al.
  Cyhoeddwyd: (2021)
• Inhibitory effect of thymoquinone from Nigella sativa against SARS-CoV-2 main protease. An in-silico study
  gan: M. T. Khan, et al.
  Cyhoeddwyd: (2022-04-01)